Outlook Therapeutics, Inc (OTLK) insider trading
Every open-market stock purchase and sale by Outlook Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Lawrence A Kenyon (CFO) and 1 other bought $211K in the last 90 days.
Last 12 months: insiders bought $12.5M (8 buys) and sold $0 (0 sales). Last close $0.65 on Sep 3, 2026.
Recent OTLK insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 1, 2026 | Kevin Michael Lundquist (CFO) | Bought (not open market) | — |
| Aug 14, 2026 | Lawrence A Kenyon (CFO) | Bought | $111K |
| Jul 29, 2026 | Faisal Ghiath Sukhtian (Director) | Bought | $100K |
| Jul 21, 2026 | Robert Charles Jahr (CEO) | Bought (not open market) | — |
| Jul 21, 2026 | Lawrence A Kenyon (CFO) | Bought (not open market) | — |
| Jun 2, 2026 | Yezan Munther Haddadin (Director) | Bought | $24.1K |
| May 28, 2026 | Ghiath M. Sukhtian (Insider) | Sold (not open market) | $12M |
| May 28, 2026 | Ghiath M. Sukhtian (Insider) | Sold (not open market) | $7.8M |
| May 28, 2026 | Ghiath M. Sukhtian (Insider) | Bought | $5M |
| May 28, 2026 | Ghiath M. Sukhtian (Insider) | Bought | $5M |
| May 28, 2026 | Ghiath M. Sukhtian (Insider) | Bought | $2M |
| May 27, 2026 | Faisal Ghiath Sukhtian (Director) | Bought | $50K |
| May 26, 2026 | Kurt J Hilzinger (Director) | Bought | $177K |
| May 26, 2026 | Yezan Munther Haddadin (Director) | Bought | $15K |
| May 26, 2026 | Randy H Thurman (Director) | Bought | $2.1K |
| Oct 3, 2025 | Gerd Auffarth (Director) | Bought (not open market) | — |
| Oct 3, 2025 | Faisal Ghiath Sukhtian (Director) | Bought (not open market) | — |
| Oct 3, 2025 | Yezan Munther Haddadin (Director) | Bought (not open market) | — |
| Oct 3, 2025 | Kurt J Hilzinger (Director) | Bought (not open market) | — |
| Oct 3, 2025 | Julia A Haller (Director) | Bought (not open market) | — |
| Oct 3, 2025 | Andong Huang (Director) | Bought (not open market) | — |
Who's trading OTLK
- Kevin Michael Lundquist, CFO: other filings, last Sep 1, 2026
- Lawrence A Kenyon, CFO: bought $111K (1 buy), last Aug 14, 2026
- Faisal Ghiath Sukhtian, Director: bought $150K (2 buys), last Jul 29, 2026
- Robert Charles Jahr, CEO: other filings, last Jul 21, 2026
- Yezan Munther Haddadin, Director: bought $39.1K (2 buys), last Jun 2, 2026
- Ghiath M. Sukhtian, 10% owner: bought $12M (3 buys), last May 28, 2026
- Randy H Thurman, Insider: bought $2.1K (1 buy), last May 26, 2026
- Kurt J Hilzinger, Director: bought $177K (1 buy), last May 26, 2026
- Gerd Auffarth, Insider: other filings, last Oct 3, 2025
- Julia A Haller, Insider: other filings, last Oct 3, 2025
- Andong Huang, Insider: other filings, last Oct 3, 2025
Get free alerts when an insider at Outlook Therapeutics, Inc files a new trade →